166 related articles for article (PubMed ID: 7991134)
21. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.
Chiba A; Kusunoki S; Shimizu T; Kanazawa I
Ann Neurol; 1992 Jun; 31(6):677-9. PubMed ID: 1514781
[TBL] [Abstract][Full Text] [Related]
22. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
23. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia.
Kusunoki S; Chiba A; Kanazawa I
Muscle Nerve; 1999 Aug; 22(8):1071-4. PubMed ID: 10417789
[TBL] [Abstract][Full Text] [Related]
24. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy.
Kusunoki S; Hitoshi S; Kaida K; Arita M; Kanazawa I
Ann Neurol; 1999 Mar; 45(3):400-3. PubMed ID: 10072058
[TBL] [Abstract][Full Text] [Related]
25. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
[TBL] [Abstract][Full Text] [Related]
26. Miller Fisher's syndrome.
Teener JW
Semin Neurol; 2012 Nov; 32(5):512-6. PubMed ID: 23677659
[TBL] [Abstract][Full Text] [Related]
27. Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides.
Jacobs BC; O'Hanlon GM; Breedland EG; Veitch J; van Doorn PA; Willison HJ
J Neuroimmunol; 1997 Dec; 80(1-2):23-30. PubMed ID: 9413256
[TBL] [Abstract][Full Text] [Related]
28. Clinical correlates of serum anti-GT1a IgG antibodies.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
J Neurol Sci; 2004 Apr; 219(1-2):139-45. PubMed ID: 15050449
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome.
Willison HJ; Veitch J
J Neuroimmunol; 1994 Mar; 50(2):159-65. PubMed ID: 8120137
[TBL] [Abstract][Full Text] [Related]
30. [A case of pharyngeal-cervical-branchial variant of Guillain-Barré syndrome with IgG anti-GT1a antibody].
Nagano K; Koga M; Yuki N
Rinsho Shinkeigaku; 1998 Apr; 38(4):333-5. PubMed ID: 9742882
[TBL] [Abstract][Full Text] [Related]
31. Isolated ptosis as acute ophthalmoplegia without ataxia, positive for anti-GQ1b immunoglobulin G.
Jindal G; Parmar VR; Gupta VK
Pediatr Neurol; 2009 Dec; 41(6):451-2. PubMed ID: 19931169
[TBL] [Abstract][Full Text] [Related]
32. [A case of Guillain-Barré syndrome with ophthalmoplegia showing high titers of anti-GQ1b and -GD1b antibodies in the serum].
Hishida R; Baba M; Ozaki I; Matsunaga M; Saitoh T
Rinsho Shinkeigaku; 1995 Mar; 35(3):306-8. PubMed ID: 7614756
[TBL] [Abstract][Full Text] [Related]
33. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
[TBL] [Abstract][Full Text] [Related]
34. [Recurrent Miller Fisher syndrome. Significance of anti-GQ1B antibodies].
Dewarrat A; Regli F; Steck A; Küntzer T
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(4):180-4. PubMed ID: 8533060
[TBL] [Abstract][Full Text] [Related]
35. Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies.
Caudie C; Quittard Pinon A; Bouhour F; Vial C; Garnier L; Fabien N
Clin Lab; 2013; 59(11-12):1277-87. PubMed ID: 24409662
[TBL] [Abstract][Full Text] [Related]
36. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
[TBL] [Abstract][Full Text] [Related]
37. [Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome].
Boussaïd I; Bouhour F; Vial C; Caudie C
Ann Biol Clin (Paris); 2011; 69(4):476-80. PubMed ID: 21896416
[TBL] [Abstract][Full Text] [Related]
38. Production of monoclonal antibodies specific for ganglioside GD3.
Watarai S; Onuma M; Yasuda T
J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
40. [A case of relapsing Guillain-Barré syndrome following Miller Fisher syndrome].
Mochizuki A; Ota K; Iijima M; Yamauchi T; Iwata M
Rinsho Shinkeigaku; 1996 May; 36(5):675-9. PubMed ID: 8905988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
